EVALUATION DURING INTRA-AORTIC BALLOON COUNTERPULSATION CORONARY AND MICROVASCULAR PHYSIOLOGY

Main Article Content

Dr Shafiq Alam
Dr Sumaiya Muhammad Iqbal Memon
Dr Ameena Palwasha
Dr Syed Soban Ahmed Tirimzi
Dr Gul Muhammad
Dr Muhammad Umair

Keywords

IABP, Circulatory Support Device, Intra-aortic balloon pump, Ischemic cardiomyopathy

Abstract

Background: This research aimed to assess how coronary autoregulation influences myocardial perfusion during the use of an Intra-aortic Balloon Pump (IABP). The IABP is a popular “circulatory support device”. Changes in microvascular function have not previously been investigated in people regarding IABP efficacy.


Methodology: The study was conducted at the National Institute of Cardiovascular Disease (NIVD) Karachi. The study included 20 “patients with ischemic cardiomyopathy left ventricular ejection fraction" 36 ± 10%) who had "percutaneous coronary intervention". Following the intervention, “intracoronary pressure and Doppler flow measurements were conducted simultaneously in the chosen vessel both unassisted and with IABP". To obtain maximum hyperemia, coronary autoregulation was changed by intracoronary adenosine. “Wave intensity analysis determined the coronary wave energies associated with ballooning counterpulsation”.


Result: “Intra-aortic balloon pump therapy” generated two distinct diastolic coronary waves: a “forward compression wave” during balloon inflation and a “forward expansion wave” during balloon deflation. Under “basal conditions, IABP increased distal coronary pressure” (84.42 ± 18.12 vs. 90.72 ± 19.82 mm Hg, p = 0.04) and “microvascular resistance” (2.342 ± 0.542 vs. 3.292 ± 0.432, p  0.002), “with no change in average peak velocity” (32.62 ± 14.02 vs. 28.62 ± 13.32, p  0.68). “When autoregulation was disabled, IABP increased average peak velocity” (41.42 ± 12.52 vs. 46.72 ± 19.52, p  0.03), and this rise was linearly related to “IABP” -forward compression wave energy (R² = 0.82, p = 0.02).


Conclusion: Autoregulation Coronary reduces the impact of “IABP on coronary blood flow”. “However, during hyperemia, IABP improves myocardial perfusion primarily due to a diastolic forward compression wave from balloon inflation”. This suggests that “IABP” is most effective when the microcirculatory reserve is depleted.

Abstract 36 | pdf Downloads 3

References

1. Gonzalez LS, Chaney MA. Intraaortic balloon pump counterpulsation, part I: history, technical aspects, physiologic effects, contraindications, medical applications/outcomes. Anesthesia & Analgesia. 2020;131(3):776-91.
2. Freund A, Desch S, Thiele H. Intra-aortic balloon counterpulsation–Does it work? Progress in Cardiovascular Diseases. 2020;63(5):623-9.
3. González LS, Grady M. Intra-aortic balloon pump counterpulsation: technical function, management, and clinical indications. International Anesthesiology Clinics. 2022;60(4):16-23.
4. van Nunen LX, van’t Veer M, Zimmermann FM, Wijnbergen I, Brueren GR, Tonino PA, et al. Intra‐aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: The SEMPER FI pilot study. Catheterization and Cardiovascular Interventions. 2020;95(1):128-35.
5. Wajeeh ZA, Hamandi SJ, Alobaidi WS, Tedy GB. Analysis of Intra-Aortic Balloon Performance in Open-Heart Surgery. Al-Nahrain Journal for Engineering Sciences. 2023;26(3):157-66.
6. James L, Dorsey MP, Kilmarx SE, Yassin S, Shrivastava S, Menghani N, et al. Intraoperative use of intra-aortic balloon pump to generate pulsatile flow during heart transplantation: A single-center experience. ASAIO Journal. 2024:10.1097.
7. Dogan EM, Axelsson B, Jauring O, Hörer TM, Nilsson KF, Edström M. Intra-aortic and Intra-caval Balloon Pump Devices in Experimental Non-traumatic Cardiac Arrest and Cardiopulmonary Resuscitation. Journal of Cardiovascular Translational Research. 2023;16(4):948-55.
8. Putowski Z, Pluta MP, Rachfalska N, Krzych ŁJ, De Backer D. Sublingual Microcirculation in Temporary Mechanical Circulatory Support: A Current State of Knowledge. Journal of Cardiothoracic and Vascular Anesthesia. 2023;37(10):2065-72.
9. Moscardelli S, Masoomi R, Villablanca P, Jabri A, Patel AK, Moroni F, et al. Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention. Current Cardiology Reports. 2024;26(4):233-44.
10. Frain K, Rees P. Intra-aortic balloon pump versus percutaneous Impella© in emergency revascularisation for myocardial infarction and cardiogenic shock: systematic review. Perfusion. 2024;39(1):45-59.
11. Kanyal R, Byrne J. The role of mechanical support devices during percutaneous coronary intervention. JRSM Cardiovascular Disease. 2021;10:20480040211014064.
12. Yang F, Wang L, Hou D, Wang J, Wang X, Cui Y, et al. Preoperative intra-aortic balloon pump inserted in acute myocardial infarction patients without cardiogenic shock undergoing surgical coronary revascularization. Perfusion. 2020;35(2):145-53.
13. Ali US, Lan NS, Gilfillan M, Ho K, Pavey W, Dwivedi G, et al. Preoperative intra-aortic balloon pumps in cardiac surgery: a propensity score analysis. Heart, Lung and Circulation. 2021;30(5):758-64.
14. Sans-Roselló J, Fernández-Peregrina E, Duran-Cambra A, Carreras-Mora J, Sionis A, Álvarez-García J, et al. Coronary microvascular dysfunction in takotsubo syndrome assessed by angiography-derived index of microcirculatory resistance: a pressure-wire-free tool. Journal of clinical medicine. 2021;10(19):4331.
15. Šerpytis R. Microcirculation Measurements in Critical and Non-critical Myocardial Ischemia: Vilniaus universitetas; 2023.
16. Akihito O, Yasuo O, Yudai T, Shohei M, Masatsugu M, Saki M, et al. Incidence of 30-day Bleeding Events in Acute Coronary Syndrome Patients Treated With Intra-Aortic Balloon Pump. 日大医学雑誌. 2023;82(3):161-9.
17. Ramasamy S. Enhanced External Counterpulsation Waveform Interpretation and Clinical Application: A Primer and Case-Based Troubleshooting Guide: Notion Press; 2020.
18. Zhang Y, Mai Z, Du J, Zhou W, Wei W, Wang H, et al. Acute effect of enhanced external counterpulsation on the carotid hemodynamic parameters in patients with high cardiovascular risk factors. Frontiers in Physiology. 2021;12:615443.
19. Kaur G, Baghdasaryan P, Natarajan B, Sethi P, Mukherjee A, Varadarajan P, et al. Pathophysiology, diagnosis, and management of coronary no-reflow phenomenon. International Journal of Angiology. 2021;30(01):015-21.
20. Purnomo Y, Nuraeni A, Anna A, Evangelista G. Use of Intra-Aortic Balloon Pump (IABP) in Patient with Ventricular Septal Rupture. Media Karya Kesehatan. 2023;6(2).

Most read articles by the same author(s)